A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Clinical trial NCT06663332 · RECRUITING

Trial details

NCT number: NCT06663332
Sponsor: Janssen Research & Development, LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Crohns Disease Colitis, Ulcerative Arthritis, Psoriatic Arthritis, Juvenile

Start date: 2024-10-29
Primary completion: 2031-12-12
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.